Novo Nordisk lifts 2024 outlook on weight-loss drug demand
Danish pharma giant Novo Nordisk lifted its 2024 outlook on Thursday and delivered better-than-expected first quarter profits as the company races to boost...
Source: dailysabah.com
Markus Manns News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Markus Manns. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Markus Manns Today - Breaking & Trending Today
Novo Nordisk raises 2024 outlook as company races to boost output of Wegovy weight-loss drug
Novo Nordisk reported better-than-expected first-quarter profits on Thursday as it looks to fend off competition from rival Eli Lilly
Source: theglobeandmail.com
Bayer investors weigh need for cash call amid stifling debt
Bayer may have to ask shareholders for fresh capital to shore up its finances even after the debt-laden German drugmaker slashed dividends last week in its latest effort to get wiggle room,...
Source: marketscreener.com
Analysis-Bayer investors weigh need for cash call amid stifling debt
Bayer may have to ask shareholders for fresh capital to shore up its finances even after the debt-laden German drugmaker slashed dividends last week in its latest effort to get wiggle room, analysts said. But new CEO Bill Anderson may struggle to win over investors, who have seen the company's value sink by two thirds since its $63 billion acquisition of Monsanto in 2018, which saddled it with costly litigation and debt. The debate over a possible share issue comes as Anderson, who was hired last June to revive the company's fortunes, prepares to deliver a strategic investor update...
Source: yahoo.com
Novo Nordisk doesn't disappoint
The Danish laboratory anticipates another year of robust double-digit growth in sales and operating profit, while beginning to ease restrictions on the supply of its popular weight loss drug, Wegovy....
Source: marketscreener.com